<?xml version="1.0" encoding="UTF-8"?>
<p>Despite the high levels of depression during ASCT hospitalization and its adverse effects on psychological adjustment and mortality following ASCT, depression is underdiagnosed and undertreated among MM patients.
 <xref rid="cam41690-bib-0009" ref-type="ref">9</xref> Moreover, current approaches to treating depression during ASCT hospitalization are limited. Pharmacological interventions, such as antidepressant medications, pose potential risks for interaction with specific drugs used during the ASCT and show little benefit over placebo.
 <xref rid="cam41690-bib-0010" ref-type="ref">10</xref> Although nonpharmacological interventions such as cognitive behavioral therapy and exercise are effective in treating depression in cancer patients,
 <xref rid="cam41690-bib-0011" ref-type="ref">11</xref>, 
 <xref rid="cam41690-bib-0012" ref-type="ref">12</xref> they are extremely difficult to implement during ASCT hospitalization due to severe patient debility. Patients are rendered emotionally and physically exhausted; they have little interest in food, television, or even conversing with family members.
</p>
